# Intensive Consolidation and Stem Cell Mobilization Therapy Followed by Autologous Stem Cell Transplantation in High-risk Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

> **NCT01555541** · PHASE2 · COMPLETED · sponsor: **C. Babis Andreadis** · enrollment: 19 (actual)

## Conditions studied

- Diffuse Large Cell Lymphoma Relapsed/Refractory

## Interventions

- **DRUG:** Ofatumumab
- **DRUG:** Etoposide
- **DRUG:** Cytarabine

## Key facts

- **NCT ID:** NCT01555541
- **Lead sponsor:** C. Babis Andreadis
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05-25
- **Primary completion:** 2017-07-06
- **Final completion:** 2021-07-01
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2022-06-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01555541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01555541, "Intensive Consolidation and Stem Cell Mobilization Therapy Followed by Autologous Stem Cell Transplantation in High-risk Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01555541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*